Menu
Log In Sign Up
Article

304 peptide prevents high-fat diet-induced increases in fasted glucose and plasma insulin levels

Published October Oct 18, 2026 7:56 AM

In the evolving landscape of biochemical research, the exploration of metabolic pathways remains a focal point for scientists worldwide. Among the compounds currently under investigation, the 304 peptide—ofte O-304 - MedChem Express n referred to in scientific literature as ATX-304 or O-304—has garnered significant attention. As someone deeply invested in the study of cellular energy regulation, I have followed the progression of this compound with great interest, particularly regarding its function as a potent AMPK activa by S Norlin·2023·Cited by 10—We here show thatAMPK activator O304 stimulates insulin independent glucose uptakeand utilization in skeletal muscle and heart in vivo, while preventing Read more tor.

The Mechanism of Action: Why ATX-304 Matters

At its core, ATX-304 is recognized as a first-in-class, orally bioavailable pan-AMPK activator. To understand its importance, one must look at the role of the AMPK protein. AMPK acts as the body's primary "energy sensor," helping to regulate vital processes such as glucose uptake and fatty-acid oxidation.

When researchers seek to activate AMPK protein pathways, they are essentially looking for ways to improve how cells handle energy. Unlike other experimental interventions, O-304 operates by suppressing the dephosphorylation of pAMPK, effectively keeping this energy sensor in an active state. This unique mechanism is why ATX-304 is designed to activate AMPK more efficiently than many traditional models.

Documented Research Findings

The data surrounding O304 is extensive and spans several areas of metabolic study. Here are some of the key observations noted in recent literature:

* Glucose Homeostasis: Studies show that AMPK activator O304 stimulates insulin independent glucose uptake and utilization, particularly in skeletal muscle and heart tissues.

* Body Composition: There is compelling evidence that ATX-304 diminishes body fat mass. In various animal models, ATX-304 has been shown to induce weight loss, often providing a parallel drop O-304 | CAS 1261289-04-6 in fat stores as verified by imag O-304 is a first-in-class, orally bioavailable pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. ing.

* Cardiovascular and Metabolic Protection: Beyond simple weight management, O304 improved peripheral microvascular perfusion and reduced blood pressure in both animal models and human subjects. This suggests that the compound can be used in studies of type 2 diabetes and related cardiovascular complications.

* Re O-304 (ATX-304) Research Peptide Powder, 2 Grams nal Support: A fascinating area of study is how the AMPK Activator ATX-304 reprograms tubular cell metabolism, potentially acting as a protective agent against injury.

Integrating ATX-304 into Research Protocols

For those sourcing this material, it is essential to distinguish between high-grade research supplies and substandard products. When looking for O-304 (ATX-304) Research Peptide Powder, purity is paramount. Most reputable suppliers provide material with a purity level of 99.9% (CAS 1261289-04-6), ensuring that the results observed in the lab are due to the compound itself rather than impurities.

It is worth noting that in certain experimental settings, ATX-304 Programs combined with metformin lowered fasting blood glucose (FPG) and insulin resistance, highlighting its potential as a synergistic tool in metabolic research. Furthermore, because O-304 is a first-in-class, orally available pan-AMPK activator, it offers a level of convenience and stability that many other peptides lack, making it a preferred choice for long-term longitudinal studies.

Final Observations

The scientific co O-304 | AMPK activator | CAS 1261289-04-6 mmunity continues to watch the development of 304 closely. Whether it is bei 2 Feb 2015—O304is in development for use in Type 2 diabetes and in Peripheral arterial disease. Phase 1a clinical studies with O304 at 100 to 2400 mg have Read more ng utilized to investigate how it prevents high-fat diet-induced increases in fasted glucose and plasma insulin levels or its broader application in metabolic reprogramming, it remains a pillar of modern biochemical research. By acting as a pioneering, orally active pan-AMPK activator, it provides a unique window into the mechanics of cellular energy balance.

*Disclaimer: This article is intended for educational and informational purposes regarding biochemical research. It does not provide medical advice, diagnosis, or recommendations for human use. Always adhere to local regulations regarding the purchase and use of research-grade compounds.*

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.